首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Effect of Frey's procedure on islet cell function in patients with chronic calcific pancreatitis
【24h】

Effect of Frey's procedure on islet cell function in patients with chronic calcific pancreatitis

机译:弗雷手术对慢性钙化性胰腺炎患者胰岛细胞功能的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Frey's procedure involves both drainage and resection of the pancreas in subjects with chronic calcific pancreatitis (CCP). The procedure may affect the pancreatic endocrine function after surgery. The present study was to evaluate the effect of Frey's procedure on both beta and alpha cell function in CCP patients. Methods: Thirty CCP patients who underwent Frey's procedure were included. According to the glycemic status, patients were divided into the diabetes mellitus (DM), prediabetes, and normal glucose tolerance (NGT) groups. Islet cell function was assessed before and 3 months after surgery. Results: At baseline, there was a significant difference in beta cell function among the three groups [NGT group 1.71 (1.64–2.07) vs prediabetes group1.50 (0.83–1.61) vs DM group 0.33 (0.12–0.55), P < 0.0001], but the insulin resistance was not different among them. Post glucose hyperglucagonemia representing alpha-cell dysfunction during oral glucose tolerance test was present in all of them, but showed no significant difference [NGT group 0.15 (0.06–0.31) vs prediabetes group 0.32 (0.05–0.70) vs DM group 0.07 (0.02–0.18), P = 0.20]. Frey's procedure did not change beta cell function and insulin resistance. However, alpha-cell dysfunction deteriorated after surgery [0.10 (0.03–0.27) vs 0.33 (0.09–0.68), P = 0.004]. Conclusions: Although Frey's procedure does not affect the beta cell function and insulin resistance in CCP patients, the alpha-cell dysfunction deteriorates after surgery.
机译:背景:Frey的手术涉及慢性钙化性胰腺炎(CCP)患者的胰腺引流和切除。该程序可能会影响手术后的胰腺内分泌功能。本研究旨在评估Frey手术对CCP患者β和α细胞功能的影响。方法:包括30例接受Frey手术的CCP患者。根据血糖状况,将患者分为糖尿病(DM),糖尿病前期和正常糖耐量(NGT)组。在手术前和手术后3个月评估胰岛细胞功能。结果:基线时,三组之间的β细胞功能存在显着差异[NGT组1.71(1.64–2.07)与糖尿病前组1.50(0.83–1.61)与DM组0.33(0.12–0.55),P <0.0001 ],但是它们之间的胰岛素抵抗没有差异。他们中均存在代表口服葡萄糖耐量试验期间α细胞功能异常的葡萄糖后高血糖症,但无显着差异[NGT组0.15(0.06-0.31)与糖尿病前组0.32(0.05–0.70)vs DM组0.07(0.02–0.02 0.18),P = 0.20]。 Frey的程序没有改变β细胞功能和胰岛素抵抗。然而,手术后α细胞功能障碍恶化[0.10(0.03-0.27)vs 0.33(0.09-0.68),P = 0.004]。结论:尽管Frey的手术方法不会影响CCP患者的β细胞功能和胰岛素抵抗,但手术后α细胞功能障碍会恶化。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2018年第004期|358-362|共5页
  • 作者单位

    Department of Endocrinology Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Endocrinology Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Endocrinology Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Medical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

    Department of Endocrinology Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:12
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号